Chronic Heart Failure (CHF) is a progressive clinical syndrome characterized by a reduced pump function of the left ventricle (chamber of the heart).
It is caused by several underlying diseases like myocardial infarction, inflammation of the heart, genetics etc. The symptoms are breathlesness, fatigue, depression, increase of body fluid. Quality of life and the prognosis of survival are poor, mostly due to an increased rate of re-hospitalization.
In Germany more than 1.8 million patients suffer from CHF, worldwide more than 26 million.
CHF is the main reason for hospital admissions in Germany. This results in costs of approximately 4.0 (40) Billion Euros (28 Billion Euros in EU and USA) per year. Therefore, CHF is a great burden for any health care system.
The individual course of CHF is characterized by approximately eight hospital re-admissions within three years.
Readmission is the real CHF-challenge
Each re-admission worsens the prognosis. Within five years after the diagnosis 50% of the patients have died and within 10 years only 10% are still alive.
These figures are still increasing despite of a lot of programs and new treatments. The individual lack of knowledge and a reduced compliance are the main drivers.
There are predictive markers, which enable us to detect the worsening of CHF approximately thirty days before symptoms occur.
Markers predicting worsening of CHF
Approximately 30 days before symptoms – like edema and shortness of breath – occur, pulmonary artery pressure increases while heart rate variability and intrathoratic impedance decrease.
Our approach enables us to identify the point of autonomous adaptation, which helps to save lifes, reduce costs and increase the quality of life for many patients.